Resultado de búsqueda
Hace 1 día · Objective Physician adherence to evidence-based clinical practice parameters impacts outcomes of amyotrophic lateral sclerosis (ALS) patients. We sought to investigate compliance with the 2009 practice parameters for treatment of ALS patients in the United States, and sociodemographic and provider characteristics associated with adherence. Methods In this population-based, retrospective cohort ...
Hace 5 días · What does the future of ALS treatments hold? Find out how clinical trials are paving the way for new and innovative therapies for this condition in our blog.
Hace 5 días · Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials. A pioneering once-a-day pill that regenerates nerve cell connections damaged by ALS has been FDA-approved for ongoing ...
Hace 1 día · QurAlis Grants Lilly Exclusive Global License for QRL-204, a Potentially First-in-Class Precision Therapy That Restores UNC13A Function in ALS and FTD - read this article along with other careers information, tips and advice on BioSpace
Hace 4 días · Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a severely debilitating, rare and ultimately fatal neurodegenerative condition caused by a combination of genetic and environmental factors. However, the causative pathogenic mechanisms in ALS remain unclear. ALS is characterised by progressive degeneration of ...
Hace 4 días · Amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease, is a neurological disorder that impacts the motor neurons responsible for controlling voluntary muscle movement and breathing, according to the National Institutes of Health (NIH). The Centers for Disease Control and Prevention (CDC) has reported that at least ...
Hace 5 días · A team of researchers at Western University, led by Dr. Michael Strong, has discovered an interaction between two proteins that could help slow or even reverse disease progression. A fragment of the RGNEF protein, named NF242, has shown promise in mitigating the effects of the TDP-43 protein, which plays a crucial role in ALS pathology.
